MMCAP - The Race to End Drug Shortages
This presentation will provide a powerful and practical perspective on drug shortages, beginning with the real-world patient impact and the life-or-death consequences when essential medicines are
Category
Format
- Live
- Webinar live
Credits
- 1.20 ABN
- 1.00 ABSWE
- 1.00 ACPE Pharmacy
- 1.00 BDEA
Event date March 23, 2026
Cost $0.00
MMCAP - Antipsychotic Update
The use of antipsychotic agents in psychiatry is ever-growing. New mechanisms are being developed and approved for managing psychosis and other disorders.
Category
Format
- Live
- Webinar live
Credits
- 1.50 ABN
- 1.25 ABSWE
- 1.25 ACPE Pharmacy
- 1.25 BDEA
Event date March 24, 2026
Cost $0.00
Gas Station Drugs: Emerging Substances, Hidden Risks, and Community Impact
The sale of unregulated and often mislabeled substances—commonly referred to as “gas station drugs”—has expanded rapidly in convenience stores and vape shops.
Category
- COACH
Format
- Webinar live
Credits
- 1.20 ABN
- 1.00 ABSWE
- 1.00 ACPE Pharmacy
- 1.00 BDEA
Event date April 8, 2026
Cost $0.00
Vaping Exposed: Health Risks, Youth Trends, and Prevention Strategies
Vaping has become one of the most prevalent forms of substance use among adolescents and young adults, driven by appealing flavors, targeted marketing, and widespread misinformation regarding safety.
Category
- COACH
Format
- Webinar live
Credits
- 1.20 ABN
- 1.00 ABSWE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 BDEA
Event date April 22, 2026
Cost $0.00
Opioids and Naloxone: Overdose Recognition, Response, and Prevention
The opioid crisis continues to impact individuals, families, and communities. Timely naloxone administration has proven to be one of the most effective tools in preventing fatal opioid overdoses, yet barriers to access, education, and stigma persist.
Category
- COACH
Format
- Webinar live
Credits
- 1.20 ABN
- 1.00 ABSWE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 BDEA
Event date May 20, 2026
Cost $0.00
Medical Cannabis in Clinical Practice: Evidence, Applications, and Cautions
Medical cannabis has gained increasing acceptance as a potential therapeutic option for a range of medical and behavioral health conditions.
Category
- COACH
Format
- Webinar live
Credits
- 1.20 ABN
- 1.00 ABSWE
- 1.00 ACPE Pharmacy
- 1.00 ACPE Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 BDEA
Event date June 3, 2026
Cost $0.00
Buprenorphine for Opioid Use Disorder: Clinical Effectiveness, Safety, and Access
Buprenorphine is a cornerstone medication for the treatment of opioid use disorder (OUD) and plays a critical role in reducing overdose risk and improving treatment retention.
Category
- COACH
Format
- Webinar live
Credits
- 1.00 ABN
- 1.00 ABSWE
- 1.00 ACPE Pharmacy
- 1.00 ACPE Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 BDEA
Event date August 12, 2026
Cost $0.00

Facebook
X
LinkedIn
Forward